Ending Deaths from Cancer


We have invented new approaches to creating personal and general cancer vaccines.  It is clear neo-antigens are key components for an effective vaccine.  We have developed technologies to discover neo-antigens that others have missed. We are testing these vaccines in dogs on the path to testing in humans. 

 11/26/2018 - New publication: https://www.nature.com/articles/s41598-018-35673-0

8/30/18 - Invited Presentation at the Immuno-Oncology Summit (Boston, MA) by Dr. Yisrael Katz, Director of Clinical Applications

4/24/18 - Featured Presentation at the European NeoAntigen Summit (Amsterdam, Netherlands) by Dr. Stephen Johnston, CEO